K
Kiora Pharmaceuticals Inc (KPRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$0.98
-0.25 (-20.16%)
Market Cap: $5.44M
Last updated: Nov 17, 2026 at 11:04 AM ET
Kiora Pharmaceuticals Inc (KPRX) Valuation Multiples
Kiora Pharmaceuticals (KPRX) trades at 6.2x sales and 0.4x book value. Its P/B of 0.4x is below its 5-year median of 0.5x. Its forward P/E is 1.7x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 1.7x |
| Price to sales | 6.2x |
| Price to book | 0.4x |
| PEG | N/A |
| FCF yield | -127.8% |
Historical Medians
Against its 10-year medians, its P/B is 66.7% below 1.2x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/B | 0.4x | 0.5x | 1.2x |
Valuation History
Over the 4 of the 10 year ends shown that have a P/S, its P/S ranged from 13.7x in 2024 to 127.6x in 2023. 2024 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $1.97 | N/A | N/A | 0.5x |
| 2024 | $3.30 | 3.8x | 13.7x | 0.4x |
| 2023 | $4.70 | N/A | 127.6x | 5.9x |
| 2022 | $30.87 | N/A | N/A | 4.9x |
| 2021 | $543.65 | N/A | N/A | 746.4x |
| 2020 | $1,774.98 | N/A | N/A | 20.7x |
| 2019 | $3,607.56 | N/A | N/A | 4.5x |
| 2018 | $2,510.54 | N/A | N/A | 20.2x |
| 2017 | $5,775.69 | N/A | 29.6x | N/A |
| 2016 | $8,798.48 | N/A | 27.4x | N/A |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About KPRX
What is KPRX's forward P/E ratio?
Kiora Pharmaceuticals has a forward P/E ratio of 1.7x.
Is KPRX stock overvalued?
GNG's valuation label for KPRX is Undervalued.
What is KPRX's price to sales ratio?
Kiora Pharmaceuticals has a price to sales ratio of 6.2x.
KPRX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors